Joseph R. Trpik JR - Oct 28, 2022 Form 4 Insider Report for EXELON CORP (EXC)

Signature
Elizabeth M. Hensen, Attorney-in-Fact for Jospeh R Trpik, Jr.
Stock symbol
EXC
Transactions as of
Oct 28, 2022
Transactions value $
$0
Form type
4
Date filed
11/1/2022, 11:36 AM
Previous filing
May 17, 2022
Next filing
Jan 25, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EXC Restricted Stock Unit Award (10/28/2022) Award +25K 25K Oct 28, 2022 Common stock 25K Direct F1
holding EXC Restricted Stock Unit Award (05/02/2022) 919 Oct 28, 2022 Common stock 919 Direct F2
holding EXC Restricted Stock Unit Award (01/28/2022) 2.91K Oct 28, 2022 Common stock 2.91K Direct F3
holding EXC Restricted Stock Unit Award (01/25/2021) 2.63K Oct 28, 2022 Common stock 2.63K Direct F4
holding EXC Restricted Stock Unit Award (01/27/2020) 1.25K Oct 28, 2022 Common stock 1.25K Direct F5
holding EXC Earned Performance RSU 7.3K Oct 28, 2022 Common stock 7.3K Direct F6
holding EXC Deferred Phantom Shares 516 Oct 28, 2022 Common stock 516 Direct F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 RSU award granted pursuant to the Exelon Long Term Incentive Plan; Award vests in 1/3 increments on the first, second and third anniversary of the grant date referenced in Column 1 subject to the reporting person's continued employment with the company. Each RSU represents the right to receive one share of Exelon common stock upon vesting. Unvested award balance accrues additional units through automatic dividend reinvestment, which vest on the same schedule as the underlying award.
F2 Additional RSU award granted in May 2022 pursuant to the Exelon Long Term Incentive Plan; this award vests in 1/3 increments on the date of the Compensation Committee's January or February meeting in the first, second and third years after the award was granted. Balance includes 13 shares acquired through automatic dividend reinvestment.
F3 Annual RSU award granted in January 2022 pursuant to the Exelon Long Term Incentive Plan; each award vests in 1/3 increments on the date of the Compensation Committee's January or February meeting in the first, second and third years after the award was granted. Balance includes 42 shares acquired through automatic dividend reinvestment.
F4 Remaining 2/3 increment of annual RSU award granted in January 2021 pursuant to the Exelon Long Term Incentive Plan; each award vests in 1/3 increments on the date of the Compensation Committee's January or February meeting in the first, second and third years after the award was granted. Balance includes 38 shares acquired through automatic dividend reinvestment.
F5 Remaining 1/3 increment of annual restricted stock unit (RSU) award granted in January 2020 pursuant to the Exelon Long Term Incentive Plan; each award vests in 1/3 increments on the date of the Compensation Committee's January or February meeting in the first, second and third years after the award was granted. Balance includes 18 shares acquired through automatic dividend reinvestment.
F6 RSU award granted pursuant to the Exelon Long Term Incentive Plan; Award cliff vests at the January 2023 meeting of the Compensation Committee with each RSU representing the right to receive one share of Exelon common stock upon vesting.
F7 Phantom share equivalents representing units held in the Exelon stock fund in a multi-fund, non-qualified deferred compensation plan. The Exelon stock fund is a unitized fund that consists of Exelon common stock and short term investments. Units of the fund will be settled upon the reporting person's separation from the company for any reason. Units will be settled in cash. Units are acquired through regular periodic contributions, company matching contributions and the reinvestment of dividend equivalents. The balance of phantom share equivalents may fluctuate due to periodic changes in the fund composition. Balance includes- 7 share equivalents earned through automatic dividend reinvestment.